Clinical Trials Browser

Phase 1/2 × Unknown × INDUSTRY × Clear all

NCT06410703 2024-10-31

CAN1012 Combined With PD-1 in Patients With Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Advanced Solid Tumor

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT03275493 2024-05-28

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04092673 2024-05-21

Zotatifin

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06173999 2024-05-14

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Phase 1/2 Unknown

Lymphoma, T-Cell, Peripheral

NCT06081686 2024-05-03

Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer

Phase 1/2 Unknown

Prostatic Neoplasms

NCT05804526 2024-04-30

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Phase 1/2 Unknown

Other solid neoplasm

Advanced Solid Tumours

NCT05458544 2024-04-29

LUCIDA

Phase 1/2 Unknown

Metastatic Castration-resistant Prostate Cancer

NCT05865925 2024-04-25

Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Advanced Solid Tumors

NCT06384235 2024-04-25

Phase II Clinical Study of LTC004 in Patients With mCRC

Phase 1/2 Unknown

Locally Advanced or Metastatic CRC

NCT06384248 2024-04-25

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Phase 1/2 Unknown

Sarcoma

NCT05240131 2024-04-12

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05519293 2024-04-11

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05552781 2024-04-11

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06308406 2024-04-11

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Phase 1/2 Unknown

Ovarian Neoplasms

NCT04469127 2024-04-10

Heroine01

Phase 1/2 Unknown

Breast Neoplasms

NCT04573192 2024-04-08

GLIOSTAR

Phase 1/2 Unknown

Glioblastoma

NCT06241235 2024-04-02

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

Phase 1/2 Unknown

Uterine Cervical Neoplasms

NCT04903873 2024-03-15

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Phase 1/2 Unknown

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT03975907 2024-03-12

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)

Phase 1/2 Unknown

Multiple Myeloma

NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06237413 2024-03-06

A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT04780217 2024-03-04

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

GastrointestinalGynecologic

Carcinoma, Hepatocellular, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04934514 2024-02-20

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Advanced Solid Tumor

NCT05991518 2024-02-20

IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

Phase 1/2 Unknown

HER2 Gene Mutation

NCT04984668 2024-02-09

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05358379 2024-02-07

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

Phase 1/2 Unknown

Lymphoma

NCT04358393 2024-02-01

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06237400 2024-02-01

A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

Phase 1/2 Unknown

Other solid neoplasm

KRAS G12C Mutant Advanced Solid Tumors

NCT05675605 2024-01-30

A Study of TY-1091 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Neoplasms, Carcinoma, Medullary

NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Phase 1/2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

NCT04983810 2024-01-25

A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

Phase 1/2 Unknown

Lymphoma

NCT06223308 2024-01-25

A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

Uterine Cervical Neoplasms

NCT06223646 2024-01-25

A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

Multiple Myeloma

NCT05186012 2024-01-23

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT06218771 2024-01-23

A Study of TQB3454 Tablets in Patients With Blood Tumors

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04284228 2024-01-16

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05906524 2024-01-10

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Advanced HCC

NCT05705505 2023-12-12

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

Phase 1/2 Unknown

Endometrioid Endometrial Cancer

NCT03614858 2023-11-29

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03896854 2023-11-29

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05745740 2023-11-27

A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02557321 2023-11-21

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

Phase 1/2 Unknown

Melanoma

NCT06126237 2023-11-13

A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

Multiple Myeloma

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Phase 1/2 Unknown

DermatologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT06111326 2023-11-01

BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04097002 2023-10-31

First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.

Phase 1/2 Unknown

Adenoviridae Infections, Prostatic Neoplasms

NCT04942067 2023-10-25

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

Amyloidosis, Multiple Myeloma

NCT04964518 2023-10-25

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06056323 2023-10-23

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult